1. Home
  2. INLX vs HOWL Comparison

INLX vs HOWL Comparison

Compare INLX & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$5.84

Market Cap

28.1M

Sector

Technology

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
HOWL
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.1M
30.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
INLX
HOWL
Price
$5.84
$0.38
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.00
AVG Volume (30 Days)
2.3K
565.3K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
$11,336.00
N/A
Revenue This Year
$16.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.31
$0.36
52 Week High
$14.57
$2.23

Technical Indicators

Market Signals
Indicator
INLX
HOWL
Relative Strength Index (RSI) 31.21 32.21
Support Level N/A N/A
Resistance Level $8.52 $0.74
Average True Range (ATR) 0.24 0.04
MACD -0.10 0.00
Stochastic Oscillator 8.52 22.57

Price Performance

Historical Comparison
INLX
HOWL

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: